{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:46:14Z","timestamp":1765295174805,"version":"3.41.2"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:p>Autism spectrum disorder (ASD) is the most common disability-causing neurodevelopmental disorder in childhood. Although inborn errors of metabolism (IEM) are rare causes of ASD, they are significant for several reasons, including implications in genetic counseling and determination of prognosis. In this article, we present a 6-year-old boy who presented to us with ASD and was diagnosed with creatine transporter deficiency. Physical and neurologic examination of this patient had not previously raised suspicion of IEM, but twin pregnancy, prematurity, NICU stay due to necrotizing enterocolitis, transient infantile hypotonia, gross-motor delay, breath-holding spells, and a single febrile seizure complicated the history. MRI revealed mild T2-hyperintensity in posterior periventricular white matter. Further evaluation with magnetic resonance spectroscopy, which showed a decreased creatine peak, led to diagnostic investigations for disorders of creatine metabolism, revealing increased urinary creatine:creatinine ratio and a de novo, novel hemizygous frameshift variant in SLC6A8. Clinicians are advised to maintain a high index of suspicion for IEM and to evaluate patients with ASD for syndromic features. Although current guidelines from relevant organizations differ in their recommendations regarding the necessity and the extent of metabolic screening in ASD, there is a growing trend toward screening for treatable IEM. In this case report, we present challenges and pitfalls in the diagnostic journey for creatine transporter deficiency and underline the significance of a thorough history and physical examination in the evaluation of a child with ASD.<\/jats:p>","DOI":"10.1542\/peds.2019-3460","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T12:35:19Z","timestamp":1603370119000},"source":"Crossref","is-referenced-by-count":10,"title":["Creatine Transporter Deficiency Presenting as Autism Spectrum Disorder"],"prefix":"10.1542","volume":"146","author":[{"given":"Y\u0131lmaz","family":"Y\u0131ld\u0131z","sequence":"first","affiliation":[{"name":"Divisions of Pediatric Metabolism and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rah\u015fan","family":"G\u00f6\u00e7men","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Yaram\u0131\u015f","sequence":"additional","affiliation":[{"name":"Private Office, Pediatric Neurology Clinic, Diyarbak\u0131r, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turgay","family":"Co\u015fkun","sequence":"additional","affiliation":[{"name":"Divisions of Pediatric Metabolism and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6knur","family":"Halilo\u011flu","sequence":"additional","affiliation":[{"name":"Pediatric Neurology, Department of Pediatrics and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2020,11,1]]},"reference":[{"issue":"2","key":"2021121019422242500_B1","first-page":"1","article-title":"Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010","volume":"63","author":"Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators","year":"2014","journal-title":"MMWR Surveill Summ"},{"issue":"10146","key":"2021121019422242500_B2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"2021121019422242500_B3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/gim.2013.32","article-title":"Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions","volume":"15","author":"Schaefer","year":"2013","journal-title":"Genet Med"},{"issue":"1","key":"2021121019422242500_B4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.30292","article-title":"Disorders of creatine transport and metabolism","volume":"157C","author":"Longo","year":"2011","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"7","key":"2021121019422242500_B5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jmedgenet-2013-101658","article-title":"Phenotype and genotype in 101 males with X-linked creatine transporter deficiency","volume":"50","author":"van de Kamp","year":"2013","journal-title":"J Med Genet"},{"issue":"1","key":"2021121019422242500_B6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0884533614557642","article-title":"Consensus statement of the Academy of Nutrition and Dietetics\/American Society for Parenteral and Enteral Nutrition: indicators recommended for the identification and documentation of pediatric malnutrition (undernutrition)","volume":"30","author":"Becker","year":"2015","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"2021121019422242500_B7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/DBP.0000000000000349","article-title":"Diagnostic evaluation of children with autism spectrum disorders: clinician compliance with published guidelines","volume":"38","author":"Tchaconas","year":"2017","journal-title":"J Dev Behav Pediatr"},{"issue":"5","key":"2021121019422242500_B8","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1542\/peds.2007-2361","article-title":"Identification and evaluation of children with autism spectrum disorders","volume":"120","author":"Johnson","year":"2007","journal-title":"Pediatrics"},{"issue":"11","key":"2021121019422242500_B9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/archdischild-2016-311271","article-title":"Current evidence-based recommendations on investigating children with global developmental delay","volume":"102","author":"Mithyantha","year":"2017","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021121019422242500_B10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-1839","article-title":"Comprehensive evaluation of the child with intellectual disability or global developmental delays","volume":"134","author":"Moeschler","year":"2014","journal-title":"Pediatrics"},{"issue":"9","key":"2021121019422242500_B11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/dmcn.12771","article-title":"Autism and inborn errors of metabolism: how much is enough?","volume":"57","author":"Asato","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"2021121019422242500_B12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/dmcn.13114","article-title":"Inborn error metabolic screening in individuals with nonsyndromic autism spectrum disorders","volume":"58","author":"Campistol","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"2021121019422242500_B13","doi-asserted-by":"crossref","first-page":"e21932","DOI":"10.1371\/journal.pone.0021932","article-title":"Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders?","volume":"6","author":"Schiff","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"2021121019422242500_B14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/apa.12169","article-title":"Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder","volume":"102","author":"Wijburg","year":"2013","journal-title":"Acta Paediatr"},{"issue":"4","key":"2021121019422242500_B15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ymgme.2014.01.011","article-title":"The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource","volume":"111","author":"van Karnebeek","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2021121019422242500_B16","doi-asserted-by":"crossref","first-page":"e20152672","DOI":"10.1542\/peds.2015-2672","article-title":"Prevalence of creatine deficiency syndromes in children with nonsyndromic autism","volume":"137","author":"Schulze","year":"2016","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-3460\/1080807\/peds_20193460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2019-3460\/1080807\/peds_20193460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T05:58:59Z","timestamp":1639202339000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/146\/5\/e20193460\/75337\/Creatine-Transporter-Deficiency-Presenting-as"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":16,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,11,1]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2019-3460","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2020,11,1]]},"article-number":"e20193460"}}